Alzheimer's disease (AD) is the most common cause of a decline in cognitive ability. It is a neurological condition involving language, memory, understanding, attention, judgment, and reasoning that often affects people over the age of 65. The disease Alzheimer's has no known treatment. There is only symptomatic therapy offered. There are two classes of medications that have been licensed for the treatment of Alzheimer's disease: partial N-methyl D-aspartate (NMDA) antagonists and cholinesterase inhibitors. Join us in this webinar to learn more about the management of Alzheimer's disease from Dr. Rahul Khemani.